Published in Cell Host Microbe on April 22, 2010
HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect Med (2012) 2.72
Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol (2012) 2.21
BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol (2010) 1.82
Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J Virol (2010) 1.60
Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog (2012) 1.60
Stimulation of NF-κB activity by the HIV restriction factor BST2. J Virol (2012) 1.56
The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol (2012) 1.50
Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc Natl Acad Sci U S A (2010) 1.39
HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio (2011) 1.30
Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci U S A (2010) 1.29
Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction. PLoS Pathog (2011) 1.29
Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology (2010) 1.26
Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog (2013) 1.24
A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog (2012) 1.21
BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology (2011) 1.20
Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. J Virol (2011) 1.18
Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol (2010) 1.17
Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses (2011) 1.13
Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J Biol Chem (2012) 1.13
Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release. J Biol Chem (2010) 1.13
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin. J Infect Dis (2011) 1.10
HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms. Mol Aspects Med (2010) 1.09
Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog (2012) 1.08
HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Traffic (2011) 1.06
Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin. J Virol (2010) 1.06
Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin. J Virol (2011) 1.05
Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology (2012) 1.05
BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathog (2011) 1.04
C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif. J Biol Chem (2011) 1.01
Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity. J Virol (2013) 1.01
BST-2 diminishes HIV-1 infectivity. J Virol (2010) 1.00
Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1. Elife (2014) 0.99
The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor? J Interferon Cytokine Res (2010) 0.98
CD317/tetherin is an organiser of membrane microdomains. J Cell Sci (2013) 0.94
Antiretroviral restriction factors. Curr Opin Virol (2011) 0.93
Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites. J Virol (2013) 0.92
Ex vivo gene therapy for HIV-1 treatment. Hum Mol Genet (2011) 0.92
Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches. Front Immunol (2013) 0.92
HIV-1 Vpu - an ion channel in search of a job. Biochim Biophys Acta (2013) 0.91
The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release. J Virol (2011) 0.90
A coiled-coil domain acts as a molecular ruler to regulate O-antigen chain length in lipopolysaccharide. Nat Struct Mol Biol (2014) 0.89
Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons. DNA Cell Biol (2011) 0.89
Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism. Front Microbiol (2011) 0.89
Tetherin and its viral antagonists. J Neuroimmune Pharmacol (2011) 0.87
Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach. Front Microbiol (2011) 0.87
A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus release. Retrovirology (2013) 0.84
Molecular mechanism of arenavirus assembly and budding. Viruses (2012) 0.83
Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells. PLoS Pathog (2015) 0.83
BST2/tetherin inhibits dengue virus release from human hepatoma cells. PLoS One (2012) 0.82
Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells. J Virol (2011) 0.82
The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release. J Biol Chem (2012) 0.81
CD4 and BST-2/tetherin proteins retro-translocate from endoplasmic reticulum to cytosol as partially folded and multimeric molecules. J Biol Chem (2013) 0.81
HIV suppression by host restriction factors and viral immune evasion. Curr Opin Struct Biol (2015) 0.81
Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation. PLoS One (2013) 0.80
Restriction of Retroviral Replication by Tetherin/BST-2. Mol Biol Int (2012) 0.80
Epitope tags beside the N-terminal cytoplasmic tail of human BST-2 alter its intracellular trafficking and HIV-1 restriction. PLoS One (2014) 0.80
The cytosolic N-terminus of CD317/tetherin is a membrane microdomain exclusion motif. Biol Open (2013) 0.79
The role of BST-2/Tetherin in host protection and disease manifestation. Immun Inflamm Dis (2015) 0.79
Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells. J Virol (2015) 0.77
A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin. Traffic (2016) 0.77
An imperfect rule for the particle roost. Cell Host Microbe (2010) 0.77
The role of BST2/tetherin in feline retrovirus infection. Vet Immunol Immunopathol (2011) 0.77
BST2/tetherin inhibition of alphavirus exit. Viruses (2015) 0.77
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses (2016) 0.77
Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions. J Virol (2013) 0.76
Virology: cleaving the tether. Nat Rev Microbiol (2010) 0.76
Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2. J Biol Chem (2014) 0.76
Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism. Viruses (2016) 0.75
Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression. J Biol Chem (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr (2005) 61.38
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr (1999) 41.65
Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr (2002) 27.16
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature (2008) 14.99
Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys J (1999) 13.18
Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr D Biol Crystallogr (1996) 11.90
Determination of domain structure of proteins from X-ray solution scattering. Biophys J (2001) 10.39
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe (2008) 9.27
Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. Acta Crystallogr D Biol Crystallogr (2003) 7.82
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08
HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe (2008) 5.90
Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A (1989) 5.72
Situs: A package for docking crystal structures into low-resolution maps from electron microscopy. J Struct Biol (1999) 5.71
Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic (2003) 5.32
Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell (2009) 5.06
Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol (2008) 4.72
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A (2009) 4.38
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe (2009) 4.36
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog (2009) 4.24
Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog (2009) 4.18
An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe (2007) 4.17
Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe (2009) 4.11
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol (1989) 3.90
Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol (2009) 3.67
Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog (2009) 3.66
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci U S A (1993) 3.63
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe (2009) 3.58
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog (2006) 3.57
Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A (2009) 3.47
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun (1999) 3.03
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog (2009) 2.92
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog (2009) 2.92
Analysis of alpha-helical coiled coils with the program TWISTER reveals a structural mechanism for stutter compensation. J Struct Biol (2002) 2.28
A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood (1994) 2.27
Deciphering the design of the tropomyosin molecule. Proc Natl Acad Sci U S A (2001) 2.14
The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology (2009) 2.11
The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol (2009) 2.00
HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J Biol Chem (2009) 1.89
Human cellular restriction factors that target HIV-1 replication. BMC Med (2009) 1.86
Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science (2008) 1.70
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol (2010) 1.63
Visualization of an unstable coiled coil from the scallop myosin rod. Nature (2003) 1.45
Improving coiled-coil stability by optimizing ionic interactions. J Mol Biol (2002) 1.34
What is the pitch of the alpha-helical coiled coil? Proteins (1992) 1.27
Crystal structures of human cardiac beta-myosin II S2-Delta provide insight into the functional role of the S2 subfragment. Proc Natl Acad Sci U S A (2006) 1.26
Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses. PLoS One (2009) 1.22
Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci (2008) 1.19
The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent. Virology (2007) 0.99
Accessories to the crime: recent advances in HIV accessory protein biology. Curr HIV/AIDS Rep (2009) 0.96
The 1.2-megabase genome sequence of Mimivirus. Science (2004) 8.37
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One (2010) 5.73
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06
Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell (2011) 4.11
Crystal structure of the rabies virus nucleoprotein-RNA complex. Science (2006) 3.48
Helical structures of ESCRT-III are disassembled by VPS4. Science (2008) 3.38
Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol (2005) 3.21
Structural basis for budding by the ESCRT-III factor CHMP3. Dev Cell (2006) 3.18
APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J Virol (2004) 3.17
Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat Struct Mol Biol (2007) 3.13
The genome sequence of Rickettsia felis identifies the first putative conjugative plasmid in an obligate intracellular parasite. PLoS Biol (2005) 2.88
Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol (2003) 2.87
Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J Virol (2003) 2.73
Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc Natl Acad Sci U S A (2006) 2.63
Genome sequence of Rickettsia bellii illuminates the role of amoebae in gene exchanges between intracellular pathogens. PLoS Genet (2006) 2.35
Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog (2010) 2.33
Structural basis for the Golgi membrane recruitment of Sly1p by Sed5p. EMBO J (2002) 2.20
Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature (2007) 2.17
Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol (2003) 2.11
X-ray structure of a neuronal complexin-SNARE complex from squid. J Biol Chem (2002) 1.82
Computational model of membrane fission catalyzed by ESCRT-III. PLoS Comput Biol (2009) 1.78
Structural basis for autoinhibition of ESCRT-III CHMP3. J Mol Biol (2008) 1.78
The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure (2003) 1.75
Analysis of the Rickettsia africae genome reveals that virulence acquisition in Rickettsia species may be explained by genome reduction. BMC Genomics (2009) 1.74
MxCuBE: a synchrotron beamline control environment customized for macromolecular crystallography experiments. J Synchrotron Radiat (2010) 1.71
X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep (2003) 1.70
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61
Cryo-electron microscopy of the giant Mimivirus. J Mol Biol (2005) 1.61
A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments. Structure (2009) 1.61
Dynamics induced by β-lactam antibiotics in the active site of Bacillus subtilis L,D-transpeptidase. Structure (2012) 1.61
Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas. EMBO J (2003) 1.56
Filovirus assembly and budding. Virology (2006) 1.56
Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54
Structural insights into the Slit-Robo complex. Proc Natl Acad Sci U S A (2007) 1.54
Structure of dimeric SecA, the Escherichia coli preprotein translocase motor. J Mol Biol (2006) 1.53
Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. Biochemistry (2003) 1.51
The use of workflows in the design and implementation of complex experiments in macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2012) 1.46
Nanobacteria are mineralo fetuin complexes. PLoS Pathog (2008) 1.42
The crystal structure of the C-terminal domain of Vps28 reveals a conserved surface required for Vps20 recruitment. Traffic (2006) 1.39
Structural basis of dynamic glycine receptor clustering by gephyrin. EMBO J (2004) 1.39
Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad Sci U S A (2007) 1.37
Solution structure of NOD1 CARD and mutational analysis of its interaction with the CARD of downstream kinase RICK. J Mol Biol (2006) 1.36
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog (2010) 1.36
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J Virol (2007) 1.33
The ESCRT pathway and HIV-1 budding. Biochem Soc Trans (2009) 1.32
Role of Ebola virus VP30 in transcription reinitiation. J Virol (2008) 1.28
VP40 octamers are essential for Ebola virus replication. J Virol (2005) 1.28
Structure of the heterotrimeric complex that regulates type III secretion needle formation. Proc Natl Acad Sci U S A (2007) 1.27
Laboratory infection of a technician by mimivirus. Ann Intern Med (2006) 1.25
The role of cellular factors in promoting HIV budding. J Mol Biol (2011) 1.21
NMR structure and ion channel activity of the p7 protein from hepatitis C virus. J Biol Chem (2010) 1.21
Automatic processing of macromolecular crystallography X-ray diffraction data at the ESRF. J Appl Crystallogr (2013) 1.19
Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol (2005) 1.18
Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol Membr Biol (2005) 1.18
Structure and function of the C-terminal domain of the polymerase cofactor of rabies virus. J Mol Biol (2004) 1.15
Divergent pathways lead to ESCRT-III-catalyzed membrane fission. Trends Biochem Sci (2010) 1.14
Dual role of MutS glutamate 38 in DNA mismatch discrimination and in the authorization of repair. EMBO J (2006) 1.12
Dynamics characterization of fully hydrated bacterial cell walls by solid-state NMR: evidence for cooperative binding of metal ions. J Am Chem Soc (2010) 1.10
Isolation and analysis of cell wall components from Streptococcus pneumoniae. Anal Biochem (2011) 1.10
Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma membrane. J Biol Chem (2011) 1.09
The use of a mini-κ goniometer head in macromolecular crystallography diffraction experiments. Acta Crystallogr D Biol Crystallogr (2013) 1.09
Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication. J Biol Chem (2013) 1.07
Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog (2010) 1.03
Solid-state NMR on bacterial cells: selective cell wall signal enhancement and resolution improvement using dynamic nuclear polarization. J Am Chem Soc (2013) 1.02
Magnesium coordination controls the molecular switch function of DNA mismatch repair protein MutS. J Biol Chem (2010) 1.02
Molecular basis of gephyrin clustering at inhibitory synapses: role of G- and E-domain interactions. J Biol Chem (2006) 1.01
Structural basis for ESCRT-III CHMP3 recruitment of AMSH. Structure (2011) 1.00
Toward the characterization of peptidoglycan structure and protein-peptidoglycan interactions by solid-state NMR spectroscopy. J Am Chem Soc (2008) 1.00
Trimeric membrane-anchored gp41 inhibits HIV membrane fusion. J Biol Chem (2004) 0.99
Structure and function of ESCRT-III. Biochem Soc Trans (2009) 0.99
Crystal structure of the GABA(A)-receptor-associated protein, GABARAP. EMBO Rep (2002) 0.98
Crenarchaeal CdvA forms double-helical filaments containing DNA and interacts with ESCRT-III-like CdvB. PLoS One (2011) 0.98
Longitudinal-relaxation-enhanced NMR experiments for the study of nucleic acids in solution. J Am Chem Soc (2009) 0.98
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. PLoS Pathog (2011) 0.98
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition. PLoS Pathog (2013) 0.97
Amino acid-type edited NMR experiments for methyl-methyl distance measurement in 13C-labeled proteins. J Am Chem Soc (2004) 0.97
Translation calibration of inverse-kappa goniometers in macromolecular crystallography. Acta Crystallogr A (2011) 0.96
Transcriptional response of Rickettsia conorii exposed to temperature variation and stress starvation. Res Microbiol (2004) 0.96
A structural basis for the biosynthesis of the major chlorogenic acids found in coffee. Plant Physiol (2012) 0.96
Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues. FEMS Microbiol Lett (2004) 0.95
Regulation of whole bacterial pathogen transcription within infected hosts. FEMS Microbiol Rev (2008) 0.95
CC2D1A is a regulator of ESCRT-III CHMP4B. J Mol Biol (2012) 0.95
Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease. J Infect Dis (2009) 0.95
Central domain of DivIB caps the C-terminal regions of the FtsL/DivIC coiled-coil rod. J Biol Chem (2009) 0.95
Subviral particle release determinants of prototype foamy virus. J Virol (2008) 0.95